![4-{[6-(3-Fluorophenyl)pyridazin-3-yl]-amino}benzoic acid - chemical structure image](https://media.scbt.com/product/4-6-3-fluorophenyl-pyridazin-3-yl-aminobenzoic-acid-structure_23_13_b_231301.jpg)
![4-{[6-(3-Fluorophenyl)pyridazin-3-yl]-amino}benzoic acid - chemical structure image](https://media.scbt.com/product/4-6-3-fluorophenyl-pyridazin-3-yl-aminobenzoic-acid-structure_23_13_t_231301.jpg "Molecular structure of 4-{[6-(3-Fluorophenyl)pyridazin-3-yl]-amino}benzoic acid")
Molecular structure of 4-{[6-(3-Fluorophenyl)pyridazin-3-yl]-amino}benzoic acid
4-{[6-(3-Fluorophenyl)pyridazin-3-yl]-amino}benzoic acid
Molecular Weight:
309.3
Molecular Formula:
C17H12FN3O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Safety Information
SDS & Certificate of Analysis
XAV939 is a potent, small molecule inhibitor of tankyrase 1 (TNKS) (IC50 = 11 nM) and tankyrase 2 (IC50 = 4 nM). By inhibiting TNKS activity, XAV939 increases the protein levels of the axin-GSK3β complex and promotes the degradation of beta-catenin in SW480 cells. At concentrations as low as 0.3 muM, XAV939 inhibits colony formation of APC-deficient colorectal cancer cells.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
4-{[6-(3-Fluorophenyl)pyridazin-3-yl]-amino}benzoic acid, 500 mg | sc-315602 | 500 mg | $180.00 |